
#10 - Dr. Stella K. Vnook, Board Chair, Founder & President at Oral Biolife
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Join us on this week's episode of our new Dental focused show, hosted by Jared S. Taylor! Our Guest: Dr. Stella K. Vnook, Board Chair, Founder & President at Oral Biolife.
What you’ll get out of this episode:
- Oral Biolife’s Innovative Approach: Introducing groundbreaking advancements in bone regeneration, targeting periodontal disease in humans and animals.
- Transformative Technology: Ambrilux Dental Gel uses a unique piezoelectric effect to stimulate bone cell activity, directly addressing periodontal health issues.
- Health Connections Beyond Dentistry: Dr. Vnook discusses links between oral health and systemic conditions, like cardiovascular disease and Alzheimer's.
- Leadership in Healthcare Innovation: Insights into Dr. Vnook’s collaborative approach to leadership, emphasizing specialized expertise.
- Future Vision for Oral Biolife: Expanding into orthopedic applications and animal health, Oral Biolife is pioneering a holistic approach to dental health care.
To Learn More About Our Guest:
Website https://oralbiolife.com/
Company's LinkedIn https://www.linkedin.com/company/oralbiolife-inc/
Guest's LinkedIn https://www.linkedin.com/in/vnook
Our sponsor for this episode is:
Milestone Scientific https://www.milestonescientific.com/
"Milestone Scientific is committed to advancing the science of computer-controlled drug delivery systems that offer significant efficiency and patient comfort gains for the medical and dentistry fields."
Show and Host's Socials:
Slice of Healthcare
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
Jared S Taylor
LinkedIn: https://www.linkedin.com/in/jaredstaylor/
WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.